Trial Profile

A 4-year Research Study to Demonstrate Value of PET Scans In Alzheimer's Disease Diagnosis

Status: Recruiting

Phase of Trial: Phase IV

Latest Information Update: 23 Oct 2019

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Florbetaben F18 (Primary) ; Florbetapir F 18 (Primary) ; Flutemetamol-F-18 (Primary)
Indications Alzheimer's disease
Focus Diagnostic use
Acronyms IDEAS

Most Recent Events

27 Mar 2019 According to a Life Molecular Imaging, Piramal imaging changed its name to Life Molecular Imaging.
19 Jul 2017 According to a Piramal Imaging media release, results from the first 3979 participants have been presented at at the 2017 Alzheimer's Association International Conference (AAIC 2017).
19 Jul 2017 Interim results published in the Alzheimer's Association media release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com